Cardinal Health (NYSE:CAH - Free Report) had its target price boosted by JPMorgan Chase & Co. from $142.00 to $145.00 in a report released on Tuesday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.
A number of other equities analysts have also commented on CAH. Mizuho assumed coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price objective on the stock. UBS Group raised their price target on Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. Barclays increased their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a report on Monday, November 4th. Finally, Wells Fargo & Company upped their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday. Four analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus target price of $136.87.
Check Out Our Latest Report on Cardinal Health
Cardinal Health Stock Performance
Shares of CAH stock traded up $0.57 on Tuesday, hitting $127.62. The company's stock had a trading volume of 1,768,220 shares, compared to its average volume of 2,397,822. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $132.84. The company has a market capitalization of $30.83 billion, a PE ratio of 23.81, a PEG ratio of 1.46 and a beta of 0.63. The stock's 50 day moving average is $122.35 and its 200-day moving average is $114.92.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, research analysts forecast that Cardinal Health will post 7.92 earnings per share for the current year.
Cardinal Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's payout ratio is currently 37.69%.
Institutional Trading of Cardinal Health
Institutional investors and hedge funds have recently bought and sold shares of the stock. Eastern Bank bought a new stake in shares of Cardinal Health in the 3rd quarter valued at about $25,000. Frazier Financial Advisors LLC lifted its stake in shares of Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after acquiring an additional 104 shares during the period. Promus Capital LLC bought a new stake in Cardinal Health in the fourth quarter valued at approximately $30,000. Hara Capital LLC acquired a new stake in Cardinal Health during the 3rd quarter valued at approximately $31,000. Finally, AM Squared Ltd bought a new position in Cardinal Health during the 3rd quarter worth approximately $33,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.
About Cardinal Health
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.